New methods, how could Norway speed up Health Technology Assessment (HTA) to the benefit of health industry, policy-makers, clinicians and patients?

Similar documents
IP7: CHANGING PARADIGM IN THE EVALUATION OF THE VALUE OF MEDICAL DEVICES: WHAT MUST STAKEHOLDERS EXPECT IN THE NEW DECADE?

Changing landscape - changing paradigms

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

Andalusian Agency for Health Technology Assessment (AETSA)

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Reflection Paper on synergies between regulatory and HTA issues. DG SANTE Unit B4 Medical products: safety, quality, innovation

December Eucomed HTA Position Paper UK support from ABHI

Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities

Biomedical Innovation Has Science Overtaken the System?

EU Cooperation on Health Technology Assessment

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

CADTH HEALTH TECHNOLOGY MANAGEMENT PROGRAM Horizon Scanning Products and Services Processes

EU s Innovative Medical Technology and EMA s Measures

Reduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered?

SHTG primary submission process

Supporting Innovation through Regulation and Science

Issues in Emerging Health Technologies Bulletin Process

European Network for Health Technology Assessment (EUnetHTA) Joint Action 3

Health Technology Assessment and the European Network for HTA

Adaptation of HTA reports: an effective way to use limited resources?

Using European Joint HTAs in local settings to adopt or to adapt, that is

EOSC Governance Development Forum 6 April 2017 Per Öster

National Coordinated Registry Network (CRN) Think-tank

Finn Børlum Kristensen, MD, PhD Director, EUnetHTA Secretariat Danish Health and Medicines Authority (EUnetHTA Coordinator) Copenhagen, Denmark

The EFPIA Perspective on the GDPR. Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference , Helsinki

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

Translational scientist competency profile

HTA, the roadmap from investment to disinvestment

Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value

The digital and trustworthy evidence ecosystem: how can health industry players join to increase value in health care and capture a global market?

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years

Tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases

EU Research Integrity Initiative

Collaboration at time of market entry (from regulatory opinion to joint REA production)

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

ABHI Response to the Kennedy short study on Valuing Innovation

Security and Risk Assessment in GDPR: from policy to implementation

Health Technology Assessment (HTA) Dr Hamid Ravaghi

Draft Plan of Action Chair's Text Status 3 May 2008

Horizon Scanning. Why & how to launch it in Lithuania? Prof. Dr. Rafael Popper

'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint

Health Technology Assessment: What are the key challenges to assess medical devices? Rosanna Tarricone, PhD Director CERGAS Scientific Director EHTI

2. Evidence themes and their importance along the development path

THEME1 STRUCTURING THE RESEARCH & DIAGNOSIS LANDSCAPE THEME DESCRIPTION SESSION 0101

Health Innovations in Horizon 2020: the framework programme for research and innovation ( )

Global Harmonization Task Force

Open Science. challenge and chance for medical librarians in Europe.

Baltic Sea Region Urban Forum for Smart Cities - a market place for smart solutions

Ethical issues raised by big data and real world evidence projects. Dr Andrew Turner

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

The Method Toolbox of TA. PACITA Summer School 2014 Marie Louise Jørgensen, The Danish Board of Technology Foundation

The impact of rapid technological change on sustainable development

Innovation for Health In the Americas: Regional Implementation of the Global Strategy on Public Health, Innovation and Intellectual Property

WHO Workshop, Bangkok, Health Technology Assessment

Software as a Medical Device (SaMD)

Health Technology Assessment (HTA): A Primer for Procurement Professionals

Medical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade

SURGERY STRATEGIC CLINICAL NETWORK EVIDENCE DECISION SUPPORT PROGRAM. New ideas & Improvements

13 December A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer

COST FP9 Position Paper

COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT. pursuant to Article 294(6) of the Treaty on the Functioning of the European Union

Roche Pharma Report Relating to EUnetHTA HTA Core Model Applications for Pharmaceuticals. December 21 st 2014

Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework. for EU Research and Innovation Funding

HTA in Norway- HTA - international challenges

THE ROLE OF GOVERNMENTS IN A CIRCULAR ECONOMY, A TRANSITION NARRATIVE

The Biological and Medical Sciences Research Infrastructures on the ESFRI Roadmap

EMA experience with the review of digital technology proposals in medicine development programmes

Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use

Alberta Health Services and Advancing Uptake of HTA & Innovation

Health Technology Strategy 1.0. June 2004

How can value be measured and assessed?

Enpr EMA. Enpr-EMA. European Network of Paediatric Research at the European Medicines Agency

Research Development Request - Profile Template. European Commission

WG/STAIR. Knut Blind, STAIR Chairman

clarification to bring legal certainty to these issues have been voiced in various position papers and statements.

Navigating the Healthcare Innovation Cycle

FRAMEWORK Advances in biomedical technology are

Digital Health and Introducing Innovative Technologies in the NHS

Medical Education Activities

Ophthalmic Digital Health Areas

Can. meet the. medicine? Healthcare SMEs. challenges of 4P.

Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective

Transformative innovation policy addressing Grand Challenges

IMI2 Intellectual Property rules in light of Call 10 topics. Magali Poinot, IMI Legal Manager IMI Stakeholder Forum 28 September 2016

Higher Education Contribution to Health Science Innovation

A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei

Meeting of the Expert Panel on effective ways of investing in health. Minutes

Policy Partnership on Science, Technology and Innovation Strategic Plan ( ) (Endorsed)

TWO BY TWO: A METHODOLOGICAL PERSPECTIVE ON THE USE OF EVIDENCE TO SUPPORT THE VALUE OF A HEALTH TECHNOLOGY

Digital Health Startups A FirstWord ExpertViews Dossier Report

Evidence for Effectiveness

NOTE Strategic Forum for International S&T Cooperation (SFIC) opinion on the ERA Framework (input to the ERAC opinion on the ERA Framework)

Health & Social Care Industrial Innovation

RECOMMENDATIONS. COMMISSION RECOMMENDATION (EU) 2018/790 of 25 April 2018 on access to and preservation of scientific information

Research and Innovation in the Defense Health Agency

FDA Centers of Excellence in Regulatory and Information Sciences

Health Technology Assessment in Developing Countries: A Brief Introduction for Vietnamese Health-care Policymakers

Final Minutes of EMA/EUnetHTA meeting

Towards Code of Conduct on Processing of Personal Data for Purposes of Scientific Research in the Area of Health

ACADEMY PROGRAMMES 1 ACADEMY OF FINLAND 2016

Transcription:

New methods, how could Norway speed up Health Technology Assessment (HTA) to the benefit of health industry, policy-makers, clinicians and patients? Department director Øyvind Melien Reviews and HTA, Norwegian Institute of Public Health (NIPH) Meeting Norway Health Tech September 28th 2018

The question is challenging A need to look into The landscape surrounding HTA The driving forces, expectations and trends Norway as a part of the international community The opportunities we have

A landscape in change Research Regulators Payers Industry HTA bodies Decisionmakers Procurement Providers Patient organizations How to organize processes? Patients

Expectations - Driving forces -Trends Unmet needs Innovations Extend documentation High speed clinical research How to find the balance points? High speed evaluation/hta Early market access Costeffectiveness Increase transparency Strengthen patient involvement Personalized medicine High quality of care

Proposal for European regulation on HTA (January 2018)

Health Technology Assessments (HTA) Built on international principles and experience Provide assessments to demonstrate added value of health technologies Promote innovations for health care

New methods - the system «Nye metoder» Norway established a system for introduction of health technologies in specialist health care from 2013 due to: Differences in practices for introduction and decision making HTA was not routinely used to inform decisions National health and care plan (2011-2015) White paper to the Parliament Quality and Patient Safety (2012) Start of Commissioning Forum (2013) and Decision Forum (2014) White paper to theparliament on Medicinal Products (2014-2015) Website launched: Nyemetoder. no (2015) White paper to the Parliament on Priority setting (2015-2016) Meeting Norway Health Tech September 28th 2018

New methods the main objectives Establish a consistent and evidence-based process for introduction of new health technologies in the specialist health care Health technology assessments chosen as a key instrument to provide a knowledge platform for decisions Ensure patients and health professionals adequate assessments of novel health technologies with reference to effect and safety Ensure predictability in processes for introduction of health technologies Meeting Norway Health Tech September 28th 2018

Health technologies broad scope Health technologies at any level in the patient pathways may be relevant for HTA Prevention of disease Diagnostics Treatment Rehabilitation Organization of health care Examples Medical technologies Medical, surgical procedures Medicinal products Meeting Norway Health Tech September 28th 2018

Process map - Nye metoder Proposal / Horizon scanning Health Technology Assessment (HTA) Priority setting decisions Implementation Input Input Proposal Horizon scanning Commissioning Forum Full HTA STA Commissioning Forum Sent to the regional health authorities for decision Decision forum May be introduced Not to be introduced Other (Ranking, disinvestment, etc.) Coordination with National Guidelines Negotiation Initiation / Local proposal Mini HTA Local decision Meeting Norway Health Tech September 28th 2018

How to speed up HTA Some examples Short term Avoid duplication of work More efficient processes for HTA Long term The role of horizon scanning A possible role for «Early dialogues» Extend access to data

Avoid duplication of work Avoid duplication of work is a major ambition with the European collaboration through EUnetHTA Joint Action 3 Increase use/reuse of HTA reports across countries Avoiding duplication should increase the total capacity for HTA

Avoid duplication of work Examples from Nye metoder Short term Use of published systematic review for patent foramen ovale (PFO)-closure adding health economic evaluation Use of published EUnetHTA report on glucose monitoring (CGM, FGM) Nye metoder has established procedure for how to reuse EUnetHTA reports

More efficient processes for HTA Long term More targeted HTA products and reports according to health problems examined Option for immediate start of collecting documentation for the health technology through literature search, data collection etc. Improve processes for involvement of clinical experts, patient representatives

The role of horizon scanning Long term Already established as integrated part of «New methods» Identification of novel upcoming health technologies at an early stage May potentially play an even more important role in future for efficient processes through «Nye metoder» Potential for stronger international collaboration

A future role for early dialogues Dialogue between industry, regulatory authorities, HTA bodies and other relevant stakeholders at an early stage in the development of new technologies Clarify needs for data both for regulatory and HTA processes Early dialogue Late dialogue Development of technology Launch Meeting Norway Health Tech September 28th 2018

Build frameworks for more efficient datasharing through the lifecycle of technologies Clinical research Evaluation of Evidence Guidelines Monitoring Reevaluation Novel research International CRIGH HTAi lnahta GIN Europe Nordic countries ECRIN Nordic Trial Alliance EUnetHTA Nordic collaboration European Guidelines GIN Nordic Implementation in Health Care Universal Health Coverage (WHO) Resolution HTA UHC 2014 Norway NORCRIN Nye metoder National Guidelines Research Data Health Data Patient experiences Data sharing - Reuse of data - Quality assurance EOSC - GOFAIR - CORBEL - extreme Data Cloud (XDC) OpenAIRE - My Health my data 17